======= PDE8A ======= == Gene Information == * **Official Symbol**: PDE8A * **Official Name**: phosphodiesterase 8A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5151|5151]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60658|O60658]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PDE8A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PDE8A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602972|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the cyclic nucleotide phosphodiesterase (PDE) family, and PDE8 subfamily. This PDE hydrolyzes the second messenger, cAMP, which is a regulator and mediator of a number of cellular responses to extracellular signals. Thus, by regulating the cellular concentration of cAMP, this protein plays a key role in many important physiological processes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2011]. * **UniProt Summary**: N/A |PDEase I| |PAS| |Response reg| |cAMP catabolic process| |3,5-cyclic-AMP phosphodiesterase activity| |cyclic nucleotide catabolic process| |3,5-cyclic-GMP phosphodiesterase activity| |negative regulation of hydrogen peroxide-induced cell death| |negative regulation of response to reactive oxygen species| |negative regulation of cellular response to drug| |cAMP metabolic process| |regulation of hydrogen peroxide-induced cell death| |negative regulation of response to drug| |purine ribonucleotide catabolic process| |ribonucleotide catabolic process| |regulation of response to reactive oxygen species| |regulation of cellular response to drug| |cyclic nucleotide metabolic process| |cellular response to epidermal growth factor stimulus| |purine nucleotide catabolic process| |negative regulation of oxidative stress-induced cell death| |negative regulation of cellular response to oxidative stress| |negative regulation of response to oxidative stress| |response to epidermal growth factor| |purine-containing compound catabolic process| |regulation of oxidative stress-induced cell death| |nucleotide catabolic process| |nucleoside phosphate catabolic process| |regulation of cellular response to oxidative stress| |regulation of response to oxidative stress| |kinase binding| |regulation of response to drug| |nucleobase-containing small molecule biosynthetic process| |organophosphate catabolic process| |carbohydrate derivative catabolic process| |positive regulation of ERK1 and ERK2 cascade| |regulation of ERK1 and ERK2 cascade| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |purine-containing compound metabolic process| |nucleobase-containing compound catabolic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organic cyclic compound catabolic process| |cellular response to growth factor stimulus| |response to growth factor| |nucleobase-containing small molecule metabolic process| |positive regulation of MAPK cascade| |small molecule biosynthetic process| |regulation of cellular response to stress| |regulation of MAPK cascade| |organophosphate metabolic process| |negative regulation of cell death| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |carbohydrate derivative metabolic process| |positive regulation of phosphorylation| |organonitrogen compound catabolic process| |nucleobase-containing compound biosynthetic process| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |organic cyclic compound biosynthetic process| |G protein-coupled receptor signaling pathway| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of response to stress| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |cellular nitrogen compound biosynthetic process| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |small molecule metabolic process| |organic substance catabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-1.84| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|1.82| |[[:results:exp292|Menadione 5μM R06 exp292]]|1.94| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|2.06| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14032 * **Expression level (log2 read counts)**: 5.46 {{:chemogenomics:nalm6 dist.png?nolink |}}